YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer

Scientists revealed the mechanisms regulating cancer-associated fibroblasts (CAFs) plasticity to identify potential strategies to switch CAFs from pro-tumorigenic to anti-tumor phenotypes and enhance immune-checkpoint inhibitor efficacy in prostate cancer.